Universitätsklinikum Heidelberg

Tebentafusp als neuartige Immuntherapie zeigt einen Überlebensvorteil beim metastasierten Uveamelanom und wird bereits in Deutschland eingesetzt. (2022) Hassel JC, Berking C Journal article Predicting major bleeding events in patients with peripheral arterial disease: the OAC(3)-PAD risk score (2022) Behrendt CA, Rother U, Uhl C, Goertz H, Stavroulakis K, Gombert A Journal article Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease (2022) Grueter T, Moellers FE, Tietz A, Dargvainiene J, Melzer N, Heidbreder A, Strippel C, et al. Journal article Effect of JAK Inhibition on the Induction of Proinflammatory HLA–DR+CD90+ Rheumatoid Arthritis Synovial Fibroblasts by Interferon-γ (2022) Zhao S, Grieshaber-Bouyer R, Rao DA, Kolb P, Chen H, Andreeva I, Tretter T, et al. Journal article Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8 (2022) Walle T, Kraske JA, Liao B, Lenoir B, Timke C, Halbach EVBU, Tran F, et al. Journal article 20 years after To Err Is Human: A bibliometric analysis of 'the IOM report's' impact on research on patient safety (2022) St. Pierre M, Grawe P, Bergstrom J, Neuhaus C Journal article The prognostic impact of Claudin 6 in papillary renal cell carcinoma (2022) Mikuteit M, Zschäbitz S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article Meta-GWAS Reveals Novel Genetic Variants Associated with Urinary Excretion of Uromodulin (2022) Joseph CB, Mariniello M, Yoshifuji A, Schiano G, Lake J, Marten J, Richmond A, et al. Journal article Advancing digital health applications: priorities for innovation in real-world evidence generation (2022) Stern AD, Brönneke J, Debatin JF, Hagen J, Matthies H, Patel S, Clay I, et al. Journal article, Review article cMET: a prognostic marker in papillary renal cell carcinoma? (2022) Erlmeier F, Bruecher B, Stoehr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article